Filing Details
- Accession Number:
- 0001415889-20-002874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-11 17:06:22
- Reporting Period:
- 2020-12-10
- Accepted Time:
- 2020-12-11 17:06:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1386570 | Chromadex Corp. | CDXC | Medicinal Chemicals & Botanical Products (2833) | 262940963 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437237 | Jr L Frank Jaksch | 10900 Wilshire Blvd. Suite 600 Los Angeles CA 90024 | Executive Chairman Of Board | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-10 | 41,667 | $4.62 | 262,168 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-10 | 37,829 | $5.19 | 224,339 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2020-12-10 | 41,667 | $0.00 | 41,667 | $4.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-05-10 | 2021-05-10 | No | 4 | M | Direct |
Footnotes
- The shares were sold to cover the cost of the exercise of the options which were scheduled to expire on May 10, 2021.
- The weighted average sale price for the transaction reported was $5.19, and the range of prices were between $5.15 and $5.25. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
Billionaire Hedge Funds
